Furthermore, the IHC analysis of EGFR protein levels (Figure 4B, left, middle, & right panels) presented positive staining of all examined breast cancer samples, for which 50% showed high intensity (right panel), 42% with medium intensity (middle panel), and only 8% showed low intensity (left panel). This evidence concerns the gene EGFR and breast cancer.